Metastatic Neuroendocrine Carcinoma

general

A neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site.

24

Centers

46

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Metastatic Neuroendocrine Carcinoma(24)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.8
2
NCI Comprehensive
High-Volume Research Center
71.8
371.8
4
NCI Comprehensive
Active Research Program
49.3
5
NCI Comprehensive
Active Research Program
49.3
6
NCI Comprehensive
Active Research Program
49.3
7
NCI Comprehensive
Active Research Program
49.3
8
NCI Comprehensive
Active Research Program
49.3
9
NCI Comprehensive
Active Research Program
49.3
10
NCI Comprehensive
Active Research Program
49.3
11
NCI Comprehensive
Active Research Program
49.3
12
NCI Clinical
Active Research Program
49.3
13
NCI Comprehensive
Active Research Program
49.3
14
NCI Comprehensive
Active Research Program
49.3
15
NCI Comprehensive
Active Research Program
49.3
16
NCI Comprehensive
Active Research Program
49.3
17
NCI Comprehensive
Active Research Program
49.3
18
NCI Comprehensive
Active Research Program
49.3
19
Active Research Program
49.3
20
NCI Comprehensive
Active Research Program
49.3
21
Active Research Program
49.3
22
Active Research Program
49.3
23
Active Research Program
49.3
24
Active Research Program
49.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →